Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans

Molecular Oral Microbiology

Volumn 25, Issue 6, 2010, Pages 418-425

  Hua, J ^a   Yamarthy, R ^a   Felsenstein, S ^a   Scott, R W ^b   Markowitz, K ^a   Diamond, G ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b PolyMedix Inc   (United States)

Author keywords

Antifungal; Defensin; Denture; Fungicide; Resistance

Indexed keywords

ANTIFUNGAL AGENT; AROMATIC AMIDE; CHLORHEXIDINE; FLUCONAZOLE; ITRACONAZOLE; PMX 30016; PMX 70004; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOTOXICITY; DENTURE; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; LIQUID CULTURE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; MOUTH CAVITY; NONHUMAN; SALIVA; THRUSH;

ACRYLIC RESINS; ALKYNES; AMIDES; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL ADHESION; BIOFILMS; BIOMIMETIC MATERIALS; CANDIDA ALBICANS; CHLORHEXIDINE; CULTURE MEDIA; DENTAL MATERIALS; DENTURE BASES; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR WEIGHT; MOUTH; PHENETHYLAMINES; PHENOLS; PYRIMIDINES; SALIVA;

EID: 78049442515     PISSN: 20411006     EISSN: 20411014     Source Type: Journal    
DOI: 10.1111/j.2041-1014.2010.00590.x     Document Type: Article

References (37)

1. Arnt, L., Rennie, J., Linser, S., Wilumeit, R. and Tew, G.N. (2006) Membrane activity of biomimetic facially amphipathic antibiotics. J Phys Chem B 110: 3527-3532.
2. Beckloff, N., Laube, D., Castro, T. et al. (2007) Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother 51: 4125-4132.
3. Benincasa, M., Scocchi, M., Pacor, S. et al. (2006) Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 58: 950-959.
4. Brogden, K.A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
5. Burrows, L.L., Stark, M., Chan, C., Glukhov, E., Sinnadurai, S. and Deber, C.M. (2006) Activity of novel non-amphipathic cationic antimicrobial peptides against Candida species. J Antimicrob Chemother 57: 899-907.
6. Chandra, J., Mukherjee, P.K., Leidich, S.D. et al. (2001a) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80: 903-908.
7. Chandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T. and Ghannoum, M.A. (2001b) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 5385-5394.
8. Chandra, J., Mukherjee, P.K. and Ghannoum, M. (2009) In vitro growth and analysis of Candida biofilms. Nat Protoc 3: 1909-1924.
9. Conti, H.R., Shen, F., Nayyar, N. et al. (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206: 299-311.
10. Diamond, G., Beckloff, N., Weinberg, A. and Kisich, K.O. (2009) The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15: 2377-2392.
11. Dupont, B., Graybill, J.R., Armstrong, D., Laroche, R., Touze, J.E. and Wheat, L.J. (1992) Fungal infections in AIDS patients. J Med Vet Mycol 30(Suppl. 1): 19-28.
12. Edgerton, M., Scannapieco, F.A., Reddy, M.S. and Levine, M.J. (1993) Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate. Infect Immun 61: 2644-2652.
13. Ghannoum, M.A. and Rice, L.B. (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517.
14. Helmerhorst, E.J., Van't Hof, W., Veerman, E.C., Simoons-Smit, I. and Nieuw Amerongen, A.V. (1997) Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem J 326 (Pt 1): 39-45.
15. Jin, Y., Zhang, T., Samaranayake, Y.H., Fang, H.H., Yip, H.K. and Samaranayake, L.P. (2005) The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 159: 353-360.
16. Kavanagh, K. and Dowd, S. (2004) Histatins: antimicrobial peptides with therapeutic potential. J Pharm Pharmacol 56: 285-289.
17. Liu, D., Choi, S., Chen, B. et al. (2004) Nontoxic membrane-active antimicrobial arylamide oligomers. Angew Chem Int Ed Engl 43: 1158-1162.
18. Meiller, T.F., Hube, B., Schild, L. et al. (2009) A novel immune evasion strategy of Candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS ONE 4: e5039.
19. Nikawa, H., Fukushima, H., Makihira, S., Hamada, T. and Samaranayake, L.P. (2004) Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Oral Dis 10: 221-228.
20. Nusslein, K., Arnt, L., Rennie, J., Owens, C. and Tew, G.N. (2006) Broad-spectrum antibacterial activity by a novel abiogenic peptide mimic. Microbiology 152: 1913-1918.
21. Oppenheim, F.G., Xu, T., McMillian, F.M. et al. (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 263: 7472-7477.
22. Rodu, B., Carpenter, J.T. and Jones, M.R. (1988) The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia. Cancer 62: 2042-2046.
23. Rotem, S. and Mor, A. (2009) Antimicrobial peptide mimics for improved therapeutic properties. Biochim Biophys Acta 1788: 1582-1592.
24. Selsted, M.E., Szklarek, D., Ganz, T. and Lehrer, R.I. (1985) Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun 49: 202-206.
25. Som, A., Vemparala, S., Ivanov, I. and Tew, G.N. (2008) Synthetic mimics of antimicrobial peptides. Biopolymers 90: 83-93.
26. Sung, W.S., Lee, J. and Lee, D.G. (2008) Fungicidal effect of piscidin on Candida albicans: pore formation in lipid vesicles and activity in fungal membranes. Biol Pharm Bull 31: 1906-1910.
27. Takakura, N., Wakabayashi, H., Ishibashi, H. et al. (2003) Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob Agents Chemother 47: 2619-2623.
28. Tang, H., Doerksen, R.J. and Tew, G.N. (2005) Synthesis of urea oligomers and their antibacterial activity. Chem Commun (Camb) 28: 1537-1539.
29. Tang, H., Doerksen, R.J., Jones, T.V., Klein, M.L. and Tew, G.N. (2006) Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones. Chem Biol 13: 427-435.
30. Tew, G.N., Clements, D., Tang, H., Arnt, L. and Scott, R.W. (2006) Antimicrobial activity of an abiotic host defense peptide mimic. Biochim Biophys Acta 1758: 1387-1392.
31. Vazquez, J.A. (2000) Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin Trials 1: 47-59.
32. Vylkova, S., Jang, W.S., Li, W., Nayyar, N. and Edgerton, M. (2007a) Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway. Eukaryot Cell 6: 1876-1888.
33. Vylkova, S., Nayyar, N., Li, W. and Edgerton, M. (2007b) Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob Agents Chemother 51: 154-161.
34. Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K. and Yamaguchi, H. (1996) Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol Immunol 40: 821-825.
35. Webb, B.C., Thomas, C.J., Willcox, M.D., Harty, D.W. and Knox, K.W. (1998) Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. Aust Dent J 43: 160-166.
36. Zasloff, M. (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84: 5449-5453.
37. Zhou, C., Qi, X., Li, P. et al. (2010) High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides. Biomacromolecules 11: 60-67.